Kolon Life Science to go public

Published: 2009-03-31 07:00:00
Updated: 2009-03-31 07:00:00
Kolon Life Science, Inc. (KLS), a subsidiary company of Kolon Group, is in the process of stepping into the secondary stock market Kosdaq.

The company is scheduled to sell 720,000 shares in its public offerings to attract investment and improve its corporate governance structure. Around 17 bil...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.